Literature DB >> 12549625

Analysis of differentially expressed genes in hepatocellular carcinoma with hepatitis C virus by suppression subtractive hybridization.

Masayo Kotaka1, George G Chen, Paul B S Lai, Wan Y Lau, Paul K S Chan, Thomas W T Leung, Authur K C Li.   

Abstract

Hepatitis C virus (HCV) infection is associated with pathogenesis of hepatocellular carcinoma (HCC). We carried out suppression subtractive hybridization to identify variable expression of genes linked to HCC with HCV infection. RNA from both tumorous (tester) and nontumorous (driver) liver tissues was isolated. The cDNA clones were subjected to MegaBACE PCR sequencing to identify those that hybridized to the subtracted library with preference. Nucleic acid sequences generated were searched against the human UniGene database. Among 576 clones screened in the tumorous liver tissue, we identified 30 genes and 28 expressed sequence tags (ESTs). Among 30 genes detected, 23 were with known functions and 7 with unknown functions. The known genes identified had diversified functions and could be divided into 10 functional categories. Twenty percent of these genes were previously known to be tumor related and those most frequently appearing were haptoglobin alpha(2FS)-beta precursor, haptoglobin related protein, and alpha-2-macroglobulin. Four out of 30 known genes (immunoglobulin lambda light chain, kappa immunoglobulin, spliceosomal protein, and X-ray repair cross-complementing protein) were related to chromosome translocation and nucleotide repair. These four genes may contribute to carcinogenesis caused by DNA-damaged agents and to the efficiency of anticancer therapy. The genes with unknown function, which were most frequently detected, were PRO2760 and PRO2955; both encode proteins that express in fetal liver. Twenty-one known and six novel genes were discovered in the nontumorous liver tissue. Apparently, these 27 genes were lost in the tumorous liver tissues. Therefore, using suppression subtractive hybridization, we have identified a number of genes associated with HCC with HCV infection. Most of these genes have not been reported in HCC. Further characterization of these differentially expressed known and unknown genes will provide useful information in understanding the genes responsible for the development of HCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12549625

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  4 in total

1.  O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma.

Authors:  Raghothama Chaerkady; Paul J Thuluvath; Min-Sik Kim; Anuradha Nalli; Perumal Vivekanandan; Jessica Simmers; Michael Torbenson; Akhilesh Pandey
Journal:  Clin Proteomics       Date:  2008-07-18       Impact factor: 3.988

2.  alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers.

Authors:  Tokuo Sukata; Satoshi Uwagawa; Keisuke Ozaki; Kayo Sumida; Kaoru Kikuchi; Masahiko Kushida; Koichi Saito; Keiichirou Morimura; Kenji Oeda; Yasuyoshi Okuno; Nobuyoshi Mikami; Shoji Fukushima
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

3.  Characteristic upregulation of glucose-regulated protein 78 in an early lesion negative for hitherto established cytochemical markers in rat hepatocarcinogenesis.

Authors:  Tokuo Sukata; Satoshi Uwagawa; Keisuke Ozaki; Kayo Sumida; Masahiko Kushida; Anna Kakehashi; Hideki Wanibuchi; Kaori Miyata; Keiko Ogata; Shoji Fukushima
Journal:  J Toxicol Pathol       Date:  2009-12-21       Impact factor: 1.628

4.  Remarkable Anticancer Activity of Teucrium polium on Hepatocellular Carcinogenic Rats.

Authors:  Ariyo Movahedi; Rusliza Basir; Asmah Rahmat; Mohammad Charaffedine; Fauziah Othman
Journal:  Evid Based Complement Alternat Med       Date:  2014-08-13       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.